Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Palisade Bio is a clinical-stage biopharmaceutical company that develops therapies for acute and chronic gastrointestinal complications.
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.
Terrestrial Bio engages in developing biomedical innovations with a focus on improving access to vaccines.
Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
Ovid Therapeutic's purpose is to solve intractable medical problems.
Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.
Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
NexCure offers clinically intense therapies in outpatient, community settings, and other cutting-edge treatments.
Atavistik Bio is a biotechnology company that develops precision allosteric small molecules aimed at treating metabolic diseases and cancer.
Candid Therapeutics develops therapies for autoimmune diseases using antibody-based technologies that modulate immune system activity.
Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.
Zura Bio is a clinical-stage, multi-asset biotechnology company.
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.
Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.
Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.
Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.
Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.
ILiAD is a clinical-stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis.
Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.
Apeiron labs mission is to provide data from the upper of the ocean.
RA Capital Management has invested in 467 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Biotechnology, Health Care, Therapeutics, Biopharma, Life Science. The firm invests across 16 different industry categories.
Among tracked funding rounds, Dianthus Therapeutics received $719.0M in a Post-IPO Equity round. RA Capital Management's total known invested capital is $56.7B.
RA Capital Management's average investment size is $123.5M across its portfolio of 467 companies.
Recent RA Capital Management portfolio additions include Palisade Bio, Vor Biopharma, Pinnacle Medicines, Terrestrial Bio, Inhibrx. These companies were founded in 2020 or later.